171 related articles for article (PubMed ID: 23607529)
1. Disease-modifying anti-rheumatic drugs for refractory severe knee synovitis in patients with peripheral spondyloarthritis: efficacy and predictors of response.
Sakellariou GT; Sayegh FE; Anastasilakis AD; Bisbinas I; Kapetanos GA
Scand J Rheumatol; 2013; 42(5):369-72. PubMed ID: 23607529
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis.
Sakellariou GT; Anastasilakis AD; Bisbinas I; Gketsos A; Berberidis C
ISRN Rheumatol; 2013; 2013():907085. PubMed ID: 23840963
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
[TBL] [Abstract][Full Text] [Related]
4. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment.
Rhodes LA; Tan AL; Tanner SF; Radjenovic A; Hensor EM; Reece R; O'Connor P; Emery P; McGonagle D
Arthritis Rheum; 2004 Aug; 50(8):2428-32. PubMed ID: 15334454
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular methotrexate in knee synovitis.
Hasso N; Maddison PJ; Breslin A
Rheumatology (Oxford); 2004 Jun; 43(6):779-82. PubMed ID: 15054155
[TBL] [Abstract][Full Text] [Related]
7. Current concepts and new developments in the treatment of psoriatic arthritis.
Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
[TBL] [Abstract][Full Text] [Related]
8. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease.
Franchini S; Dagna L; Salvo F; Aiello P; Baldissera E; Sabbadini MG
Arthritis Rheum; 2010 Aug; 62(8):2530-5. PubMed ID: 20506370
[TBL] [Abstract][Full Text] [Related]
10. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
Weitoft T; Larsson A; Saxne T; Rönnblom L
Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449
[TBL] [Abstract][Full Text] [Related]
11. [Seronegative spondylarthropathy: variable manifestations, common characteristics].
van Rijthoven AW; Jacobs JW
Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1377-81. PubMed ID: 17668597
[TBL] [Abstract][Full Text] [Related]
12. Psoriatic uveitis: a distinct clinical entity?
Durrani K; Foster CS
Am J Ophthalmol; 2005 Jan; 139(1):106-11. PubMed ID: 15652834
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
Kruithof E; De Rycke L; Roth J; Mielants H; Van den Bosch F; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
[TBL] [Abstract][Full Text] [Related]
14. Clinical courses and predictors of outcomes in patients with monoarthritis: a retrospective study of 171 cases.
Jeong H; Kim AY; Yoon HJ; Park EJ; Hwang J; Kim H; Ahn JK; Lee J; Koh EM; Cha HS
Int J Rheum Dis; 2014 Jun; 17(5):502-10. PubMed ID: 24330384
[TBL] [Abstract][Full Text] [Related]
15. Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Silva-Fernández L; Pérez-Vicente S; Martín-Martínez MA; López-González R;
Semin Arthritis Rheum; 2015 Jun; 44(6):633-40. PubMed ID: 25563529
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis.
Marzo-Ortega H; Green MJ; Keenan AM; Wakefield RJ; Proudman S; Emery P
Arthritis Rheum; 2007 Feb; 57(1):154-60. PubMed ID: 17266089
[TBL] [Abstract][Full Text] [Related]
17. Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry.
López-Medina C; Ortega-Castro R; Castro-Villegas MC; Font-Ugalde P; Puche-Larrubia MÁ; Gómez-García I; Arias-de la Rosa I; Barbarroja N; Schiotis R; Collantes-Estévez E
Rheumatology (Oxford); 2021 Mar; 60(3):1125-1136. PubMed ID: 32856083
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
[TBL] [Abstract][Full Text] [Related]
19. Ten-year follow-up of SpA-related oligoarthritis involving the knee: the presence of psoriasis but not HLA-B27 or baseline MRI bone oedema predicts outcome.
Bennett AN; Marzo-Ortega H; Tan AL; Hensor EM; Green M; Emery P; McGonagle D
Rheumatology (Oxford); 2012 Jun; 51(6):1099-106. PubMed ID: 22328564
[TBL] [Abstract][Full Text] [Related]
20. [Uveitis in spondyloarthritis].
Rudwaleit M; Walscheid K; Heiligenhaus A
Z Rheumatol; 2017 Oct; 76(8):682-692. PubMed ID: 28812149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
